Our experimental data suggest that DARC isoforms in the tumor microenvironment could reduce the levels of pro-malignant chemokines (such as CCL2, CCL5, and CXCL8) in different degrees, have differential effects on tumor growth and vascularization, and contribute to differential potential of metastasis. This evidence concerns the gene CCL5 and neoplasm.